학술논문
Complete Pathologic Response to Pembrolizumab and Axitinib in a Patient With Sarcomatoid RCC and Ocrelizumab-Treated Multiple Sclerosis
Document Type
Article
Author
Source
In: Urology . (Urology, June 2022, 164:50-54)
Subject
Language
English
ISSN
15279995
00904295
00904295